Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages

Abstract Iron is a crucial micronutrient for both mammals and their associated pathogens, and extensive literature has shown that Mycobacterium tuberculosis (Mtb) bacilli inhibited from acquiring iron from the host are severely attenuated. In contrast, increased dietary iron concentrations or patien...

Full description

Bibliographic Details
Main Authors: Rodrigo Abreu, Lauren Essler, Allyson Loy, Frederick Quinn, Pramod Giri
Format: Article
Language:English
Published: Nature Portfolio 2018-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-25480-y
_version_ 1818405761570570240
author Rodrigo Abreu
Lauren Essler
Allyson Loy
Frederick Quinn
Pramod Giri
author_facet Rodrigo Abreu
Lauren Essler
Allyson Loy
Frederick Quinn
Pramod Giri
author_sort Rodrigo Abreu
collection DOAJ
description Abstract Iron is a crucial micronutrient for both mammals and their associated pathogens, and extensive literature has shown that Mycobacterium tuberculosis (Mtb) bacilli inhibited from acquiring iron from the host are severely attenuated. In contrast, increased dietary iron concentrations or patients with hemochromatosis have long been associated with a more severe tuberculosis (TB) disease outcome. We have observed that upon macrophage infection, Mtb bacilli strongly promote intracellular iron sequestration, both through increased expression of hepcidin, a key mammalian iron regulatory protein, and downregulation of the iron exporter protein, ferroportin. Heparin is a highly sulfated glycosaminoglycan released by mast cells and basophils at sites of tissue injury. During Mtb infection, heparin alters intracellular trafficking in alveolar epithelial cells and decreases extrapulmonary dissemination but recently, heparin also has been reported to inhibit hepcidin expression in hepatocytes, decreasing intracellular iron availability. In this report, we demonstrate that heparin significantly reduces hepcidin expression in macrophages infected with Mtb bacilli. Heparin-treated macrophages have higher ferroportin expression compared to untreated macrophages, promoting iron export and decreasing iron availability to intracellular bacilli. Thus, here we describe a novel immunomodulatory effect and potential therapeutic role for heparin against mycobacterial infection in human macrophages.
first_indexed 2024-12-14T09:01:11Z
format Article
id doaj.art-8d2b790173db44289b522a6156c41789
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T09:01:11Z
publishDate 2018-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8d2b790173db44289b522a6156c417892022-12-21T23:08:49ZengNature PortfolioScientific Reports2045-23222018-05-018111210.1038/s41598-018-25480-yHeparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophagesRodrigo Abreu0Lauren Essler1Allyson Loy2Frederick Quinn3Pramod Giri4Department of Infectious Diseases, College of Veterinary Medicine, University of GeorgiaDepartment of Infectious Diseases, College of Veterinary Medicine, University of GeorgiaDepartment of Infectious Diseases, College of Veterinary Medicine, University of GeorgiaDepartment of Infectious Diseases, College of Veterinary Medicine, University of GeorgiaDepartment of Infectious Diseases, College of Veterinary Medicine, University of GeorgiaAbstract Iron is a crucial micronutrient for both mammals and their associated pathogens, and extensive literature has shown that Mycobacterium tuberculosis (Mtb) bacilli inhibited from acquiring iron from the host are severely attenuated. In contrast, increased dietary iron concentrations or patients with hemochromatosis have long been associated with a more severe tuberculosis (TB) disease outcome. We have observed that upon macrophage infection, Mtb bacilli strongly promote intracellular iron sequestration, both through increased expression of hepcidin, a key mammalian iron regulatory protein, and downregulation of the iron exporter protein, ferroportin. Heparin is a highly sulfated glycosaminoglycan released by mast cells and basophils at sites of tissue injury. During Mtb infection, heparin alters intracellular trafficking in alveolar epithelial cells and decreases extrapulmonary dissemination but recently, heparin also has been reported to inhibit hepcidin expression in hepatocytes, decreasing intracellular iron availability. In this report, we demonstrate that heparin significantly reduces hepcidin expression in macrophages infected with Mtb bacilli. Heparin-treated macrophages have higher ferroportin expression compared to untreated macrophages, promoting iron export and decreasing iron availability to intracellular bacilli. Thus, here we describe a novel immunomodulatory effect and potential therapeutic role for heparin against mycobacterial infection in human macrophages.https://doi.org/10.1038/s41598-018-25480-y
spellingShingle Rodrigo Abreu
Lauren Essler
Allyson Loy
Frederick Quinn
Pramod Giri
Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
Scientific Reports
title Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
title_full Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
title_fullStr Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
title_full_unstemmed Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
title_short Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
title_sort heparin inhibits intracellular mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages
url https://doi.org/10.1038/s41598-018-25480-y
work_keys_str_mv AT rodrigoabreu heparininhibitsintracellularmycobacteriumtuberculosisbacterialreplicationbyreducingironlevelsinhumanmacrophages
AT laurenessler heparininhibitsintracellularmycobacteriumtuberculosisbacterialreplicationbyreducingironlevelsinhumanmacrophages
AT allysonloy heparininhibitsintracellularmycobacteriumtuberculosisbacterialreplicationbyreducingironlevelsinhumanmacrophages
AT frederickquinn heparininhibitsintracellularmycobacteriumtuberculosisbacterialreplicationbyreducingironlevelsinhumanmacrophages
AT pramodgiri heparininhibitsintracellularmycobacteriumtuberculosisbacterialreplicationbyreducingironlevelsinhumanmacrophages